| Contour SE™ Microspheres
In 2002, Boston Scientific introduced the Contour
SE™ microspheres in the U.S. to treat hypervascular tumors
and arteriovenous malformations (AVMs). We are currently awaiting
a CE Mark to begin sales in Europe. The Contour SE product is made
of polyvinyl alcohol (PVA), a material that has been used extensively
in embolization procedures for more than 20 years. The Contour SE
product is designed to shrink and destroy hypervascular tumors and
AVMs by blocking the blood supply.
In addition, Boston Scientific has received FDA authorization
to perform clinical trials to evaluate the use of the Contour SE
product for the treatment of uterine fibroids. Upon approval, the
Contour SE product will provide an alternative to myomectomy and
hysterectomy – the standard surgical therapies for uterine
fibroids.
|
